Subcutaneous Drug Delivery Devices Market Forecast Signals New Revenue Opportunities Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Subcutaneous Drug Delivery Devices Market Size Forecast: How Large Could The Market Become By 2030?
The subcutaneous drug delivery devices market has seen robust expansion in recent years. Its value is projected to rise from $29.77 billion in 2025 to $32.03 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.6%. Several factors drove this growth in the historical period, including the increasing incidence of diabetes and chronic illnesses, a higher adoption rate of insulin pens and pen needles, enhanced hospital and clinic infrastructure, restricted access to sophisticated delivery technologies, and greater awareness regarding subcutaneous drug administration.
The subcutaneous drug delivery devices market is anticipated to experience robust expansion over the coming years, projected to reach $42.42 billion by 2030, advancing at a compound annual growth rate (CAGR) of 7.3%. This forecasted growth is driven by several factors, including the expansion of biologics and oncology therapies, the increased use of smart auto-injectors, the broadening of homecare settings, innovations in implantable pump technologies, and a growing demand for patient-focused drug delivery solutions. Key developments in the market encompass the widespread uptake of auto-injectors and smart injection devices, a shift toward home-based and self-administration treatment approaches, a heightened preference for minimally invasive delivery techniques, the extension of delivery applications for biologics and biosimilars, and enhanced patient adherence driven by ergonomic device designs.
Download A Free Sample Report For Comprehensive Market Insights:
Subcutaneous Drug Delivery Devices Market Demand Drivers Creating New Revenue Opportunities
The market for subcutaneous drug delivery devices is anticipated to expand due to the rising occurrence of diabetes and cardiovascular diseases (CVD). Factors such as aging populations, poor dietary habits, sedentary lifestyles, obesity, socioeconomic disparities, stress, environmental influences, and restricted access to preventive care are fueling the growing prevalence of these conditions. These devices are employed in diabetes management to deliver insulin and other medications for glycemic control, while in cardiovascular disease care, they administer drugs like anticoagulants or lipid-lowering agents, providing a practical and regulated approach to managing these long-term illnesses. For example, the Centers for Disease Control and Prevention, a federal agency based in the United States, reported in October 2024 that cardiovascular disease claimed 919,032 lives in 2023, accounting for roughly one out of every three deaths. Consequently, this increasing incidence of diabetes and CVD is fueling growth in the subcutaneous drug delivery devices sector.
Subcutaneous Drug Delivery Devices Market Categorization By Product Type And Application
The subcutaneous drug delivery devices market covered in this report is segmented –
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) By Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) By Pen Needles: Standard Pen Needles, Safety Pen Needles
3) By Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) By Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) By Implantable Pumps: Insulin Pumps, Drug Infusion Pumps
Subcutaneous Drug Delivery Devices Market Trends Driving Strategic Industry Expansion
Leading players in the subcutaneous drug delivery devices industry are prioritizing the creation of cutting-edge solutions, such as compact digital liquid flow sensors, to improve the security and accuracy of drug administration under the skin by delivering tailored, reliable flow sensors suitable for high-volume injectors. These miniature digital liquid flow sensors are small instruments that exactly gauge the flow speed of fluids in small-scale uses, offering digital outputs for exact monitoring and command. For example, in May 2024, Sensirion AG, a Swiss firm specializing in environmental and flow sensing technologies, introduced the SLD3x series sensor platform. This sensor range includes highly precise digital liquid flow sensors with adaptable features, enabling exact flow measurement, obstruction detection, real-time air bubble recognition, and fluid temperature surveillance. These tiny sensors are perfect for the mass production of medical devices, guaranteeing correct dosing and better patient safety during subcutaneous drug delivery.
Subcutaneous Drug Delivery Devices Market Company Landscape And Strategic Competition
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.
Access The Complete Subcutaneous Drug Delivery Devices Market Report:
Subcutaneous Drug Delivery Devices Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the subcutaneous drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
